Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Ranbaxy announces new co-packaged triple ART combinations

Indian pharmaceutical manufacturer Ranbaxy announced yesterday the launch of two new co-packaged triple combinations of d4T, 3TC and efavirenz, and AZT, 3TC and efavirenz. The

Published
02 December 2005
By
Keith Alcorn
Some groups get more benefit from anti-HIV drugs than others

Some groups of patients appear more likely to derive a benefit from antiretroviral therapy in the first year of treatment than others, a study published

Published
08 November 2005
By
Michael Carter
Poor immmunologic response to HAART should be cause for concern in viral load responders

Canadian investigators have established that individuals who do not experience both an increase in their CD4 cell count of at least 50 cells/mm3, and a

Published
07 November 2005
By
Michael Carter
Selective taking of anti-HIV drugs associated with higher rate of AIDS and death

A significant minority of individuals taking combinations of anti-HIV drugs selectively miss doses of specific drugs, American researchers have found. Writing in the November 1st

Published
03 November 2005
By
Michael Carter
Directly observed therapy shown to be of value for some patients

A modified form of directly observed therapy (often abbreviated as DOTS) can increase the effectiveness of antiretroviral therapy amongst a subset of HIV-positive patients with

Published
16 August 2005
By
Michael Carter
Manchester’s oldest HIV self-help group faces closure in September

Body Positive North West (BPNW), an HIV self-help charity established for 20 years, providing over 1200 HIV-positive individuals in and around Greater Manchester with drug

Published
07 July 2005
By
Edwin J. Bernard
Sexual transmission of HCV found in Swiss HIV-positive gay men

Unprotected sex is associated with new hepatitis C virus infections in Swiss HIV-positive gay men, according to a study published in the August 1st edition

Published
22 June 2005
By
Michael Carter
Response to HAART improves due to better drugs and more expertise in their use

Between 1996 and 2002 there was a significant improvement in the proportion of patients starting highly active antiretroviral therapy (HAART) who achieved suppression of HIV

Published
13 June 2005
By
Michael Carter
Low level and intermittent HIV replication during very early infection

Low levels of HIV are present in the plasma of individuals during the very early stages of primary HIV infection, according to a United States

Published
08 June 2005
By
Michael Carter
HAART use and good adherence means less risky sex says Californian study

Use of, and adherence to, HAART is associated with less sexual risk taking, according to a study conducted in California and published in the June

Published
25 May 2005
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.